Lymphadenopathic aggressive Kaposi's sarcoma in a renal transplant recipient with HLA-DR2 and HLA-DR5 antigens.
Sungur
C
C
Bozdogan
O
O
Sungur
A
A
Oymak
O
O
Yasavul
U
U
Turgan
C
C
Caglar
S
S
D000328:Adult; D015802:HLA-DR2 Antigen / Q000032:analysis*; D015805:HLA-DR5 Antigen / Q000032:analysis*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology*; D008206:Lymphatic Diseases / Q000209:etiology* / Q000276:immunology* / Q000473:pathology; D008297:Male; D012514:Sarcoma, Kaposi / Q000209:etiology* / Q000276:immunology* / Q000473:pathology
D015802:HLA-DR2 Antigen; D015805:HLA-DR5 Antigen